Angiotensin converting enzyme (ACE) inhibitors are increasingly important in antihypertensive therapy, with newer agents offering potential advantages over older ones that remain to be proven.
ACE inhibitors are effective and well-tolerated for hypertension management, though the specific advantages of newer agents over older ones remain to be proven.
Angiotensin converting enzyme (ACE) inhibitors are increasingly important in antihypertensive therapy because of their efficacy, tolerability, and specific benefits in subsets of patients. They are pharmacologically diverse. Whereas most benefits have been proven with older agents (captopril, enalopril), newer agents, such as benazepril, quinapril, and ramipril, offer potential advantages that remain to be proven.
James F. Burris (1995) conducted a review in Hypertension. Angiotensin converting enzyme (ACE) inhibitors was evaluated. Angiotensin converting enzyme (ACE) inhibitors are increasingly important in antihypertensive therapy, with newer agents offering potential advantages over older ones that remain to be proven.